Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Feb 9;10(2):183.
doi: 10.3390/pathogens10020183.

Understanding Human Microbiota Offers Novel and Promising Therapeutic Options against Candida Infections

Affiliations
Review

Understanding Human Microbiota Offers Novel and Promising Therapeutic Options against Candida Infections

Saif Hameed et al. Pathogens. .

Abstract

Human fungal pathogens particularly of Candida species are one of the major causes of hospital acquired infections in immunocompromised patients. The limited arsenal of antifungal drugs to treat Candida infections with concomitant evolution of multidrug resistant strains further complicates the management of these infections. Therefore, deployment of novel strategies to surmount the Candida infections requires immediate attention. The human body is a dynamic ecosystem having microbiota usually involving symbionts that benefit from the host, but in turn may act as commensal organisms or affect positively (mutualism) or negatively (pathogenic) the physiology and nourishment of the host. The composition of human microbiota has garnered a lot of recent attention, and despite the common occurrence of Candida spp. within the microbiota, there is still an incomplete picture of relationships between Candida spp. and other microorganism, as well as how such associations are governed. These relationships could be important to have a more holistic understanding of the human microbiota and its connection to Candida infections. Understanding the mechanisms behind commensalism and pathogenesis is vital for the development of efficient therapeutic strategies for these Candida infections. The concept of host-microbiota crosstalk plays critical roles in human health and microbiota dysbiosis and is responsible for various pathologies. Through this review, we attempted to analyze the types of human microbiota and provide an update on the current understanding in the context of health and Candida infections. The information in this article will help as a resource for development of targeted microbial therapies such as pre-/pro-biotics and microbiota transplant that has gained advantage in recent times over antibiotics and established as novel therapeutic strategy.

Keywords: Candida; gastrointestinal; gut; metabolite; microbiota; nasopharyngeal; oral; vaginal.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Shoham S., Levitz S.M. The Immune Response to Fungal Infections. Br. J. Haematol. 2005;129:569–582. doi: 10.1111/j.1365-2141.2005.05397.x. - DOI - PubMed
    1. Hazen K.C. New and Emerging Yeast Pathogens. Clin. Microbiol. Rev. 2005;8:462–478. doi: 10.1128/CMR.8.4.462. - DOI - PMC - PubMed
    1. Fridkin S.K., Jarvis W.R. Epidemiology of Nosocomial Fungal Infections. Clin. Microbiol. Rev. 1996;9:499–511. doi: 10.1128/CMR.9.4.499. - DOI - PMC - PubMed
    1. Barnett J.A. A History of Research on Yeasts 2: Louis Pasteur and His Contemporaries, 1850–1880. Yeast. 2000;16:755–771. doi: 10.1002/1097-0061(20000615)16:8<755::AID-YEA587>3.0.CO;2-4. - DOI - PubMed
    1. Pfaller M., Wenzel R. Impact of the changing epidemiology of fungal infections in the 1990s. Eur. J. Clin. Microbiol. Infect. Dis. 1992;11:287–291. doi: 10.1007/BF01962067. - DOI - PubMed

LinkOut - more resources